Latest Insider Transactions at Brightcove Inc (BCOV)
This section provides a real-time view of insider transactions for Brightcove Inc (BCOV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BRIGHTCOVE INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BRIGHTCOVE INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2022
|
Thomas E Wheeler Director |
BUY
Open market or private purchase
|
Direct |
6,200
+11.31%
|
$43,400
$7.9 P/Share
|
|
Dec 10
2021
|
Jeff Ray Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,453
-2.69%
|
$130,077
$9.66 P/Share
|
|
Dec 10
2021
|
Robert Noreck Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,033
-1.3%
|
$72,297
$9.66 P/Share
|
|
Dec 10
2021
|
David Plotkin Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,023
-1.59%
|
$72,207
$9.66 P/Share
|
|
Dec 01
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
104
+0.0%
|
$936
$9.25 P/Share
|
|
Nov 23
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
70,300
+0.74%
|
$632,700
$9.84 P/Share
|
|
Nov 16
2021
|
Jeff Ray Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+0.61%
|
$50,000
$10.27 P/Share
|
|
Nov 16
2021
|
Deborah M. Besemer Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,456
+5.02%
|
$37,280
$5.9 P/Share
|
|
Nov 15
2021
|
Jeff Ray Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+1.84%
|
$50,000
$10.2 P/Share
|
|
Nov 12
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,022
+0.24%
|
$110,220
$10.19 P/Share
|
|
Nov 11
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
38,978
+0.84%
|
$389,780
$10.17 P/Share
|
|
Nov 01
2021
|
Robert Noreck Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
90,544
+30.22%
|
-
|
|
Nov 01
2021
|
David Plotkin Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,423
+29.24%
|
-
|
|
Oct 04
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
39,975
+0.22%
|
$439,725
$11.23 P/Share
|
|
Sep 22
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,407
+0.03%
|
$14,070
$10.98 P/Share
|
|
Sep 21
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,291
+0.19%
|
$190,201
$11.01 P/Share
|
|
Sep 20
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
13,200
+0.15%
|
$132,000
$11.0 P/Share
|
|
Sep 17
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
28,790
+0.21%
|
$316,690
$11.33 P/Share
|
|
Sep 16
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,882
+0.09%
|
$42,702
$11.35 P/Share
|
|
Sep 15
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
9,150
+0.2%
|
$100,650
$11.39 P/Share
|
|
Sep 10
2021
|
David Plotkin Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,330
-1.31%
|
$15,960
$12.16 P/Share
|
|
Aug 31
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
16,839
+0.37%
|
$185,229
$11.37 P/Share
|
|
Aug 30
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,000
+0.11%
|
$55,000
$11.43 P/Share
|
|
Aug 26
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
37,935
+0.43%
|
$417,285
$11.39 P/Share
|
|
Aug 23
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200
+0.0%
|
$2,200
$11.35 P/Share
|
|
Aug 20
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
17,470
+0.39%
|
$192,170
$11.4 P/Share
|
|
Aug 17
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
45,226
+0.34%
|
$497,486
$11.23 P/Share
|
|
Aug 16
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
14,191
+0.33%
|
$156,101
$11.39 P/Share
|
|
Aug 13
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,223
+0.14%
|
$68,453
$11.45 P/Share
|
|
Aug 05
2021
|
Edenbrook Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,000
+0.02%
|
$11,000
$11.26 P/Share
|
|
Jul 31
2021
|
Robert Noreck Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
917
-0.77%
|
$10,087
$11.47 P/Share
|
|
Jun 16
2021
|
Robert Noreck Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
36,206
+23.26%
|
-
|
|
May 18
2021
|
Deborah M. Besemer Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+6.37%
|
-
|
|
May 18
2021
|
Kristin E. Frank Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+20.16%
|
-
|
|
May 18
2021
|
Gary E Haroian Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+18.06%
|
-
|
|
May 18
2021
|
Diane Hessan Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+17.36%
|
-
|
|
May 18
2021
|
Scott Kurnit Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+7.55%
|
-
|
|
May 18
2021
|
Tsedal Neeley Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+31.2%
|
-
|
|
May 18
2021
|
Ritcha Ranjan Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+33.5%
|
-
|
|
May 18
2021
|
Thomas E Wheeler Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,090
+17.65%
|
-
|
|
Apr 28
2021
|
Jeff Ray Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
44,712
-14.56%
|
$849,528
$19.45 P/Share
|
|
Apr 28
2021
|
Robert Noreck Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,015
-3.95%
|
$133,285
$19.45 P/Share
|
|
Apr 28
2021
|
David Plotkin Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,113
-11.46%
|
$249,147
$19.45 P/Share
|
|
Mar 26
2021
|
David Plotkin Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
27,027
-9.91%
|
$540,540
$20.68 P/Share
|
|
Mar 12
2021
|
Tsedal Neeley Director |
BUY
Open market or private purchase
|
Direct |
2,000
+15.44%
|
$44,000
$22.11 P/Share
|
|
Feb 25
2021
|
David Plotkin Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
518
+0.36%
|
$4,144
$8.19 P/Share
|
|
Dec 30
2020
|
Jeff Ray Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,190
+14.05%
|
-
|
|
Dec 30
2020
|
Robert Noreck Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,094
+17.46%
|
-
|
|
Dec 30
2020
|
David Plotkin Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,275
+9.78%
|
-
|
|
Dec 10
2020
|
David Plotkin Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,220
-1.09%
|
$71,740
$17.32 P/Share
|